• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Top 5 Biosimilar Articles for the Week of February 26

News
Video

Here are the top 5 articles for the week of February 26, 2024.

Number 5:The Revolution that Died on its Way to Dinner Table,” reported in the New York Times on February 9, summed up the history of the gleaming vision of a world just beyond the present: a world in which a high-tech factory housing bioreactors will produce formed steaks, millions of pounds a day to feed the world at an affordable cost—highly affordable biosimilar steaks.

Number 4: At the Congress of European Crohn’s and Colitis Organisation (ECCO), Celltrion and Samsung Bioepis presented new finding from their respective biosimilar analyses, demonstrating positive safety and efficacy measures for the biosimilars as treatments for Crohn disease (CD) and ulcerative colitis (UC).

Number 3: The US Department of Veterans Affairs (VA) has chosen to replace Humira (adalimumab) with Organon’s biosimilar version on its national formulary; Biocon Biologics and Sandoz announce a new partnership in Australia for 2 biosimilars; Alvotech settles with Johnson & Johnson over its biosimilar to Stelara (ustekinumab) for the European and Canadian markets.

Number 2: Unbranded biologics primarily serve to uphold inflated list prices, typically prompted by loss of exclusivity, aiming to safeguard market share and counter biosimilar competition, although forthcoming legislative changes targeting high drug costs could lessen their significance moving forward.

Number 1: After receiving several complete response letters (CRLs), Alvotech has officially received FDA approval for its adalimumab biosimilar (AVT02; Simlandi), making it the first US approval for the company and tenth biosimilar referencing Humira (adalimumab). The product was also approved as an interchangeable biosimilar.

To read all of these articles and more, visit centerforbiosimilars.com.

Related Videos
The Top 5 Biosimilars Articles for the Week of April 8, 2024.
Ha Kung Wong, JD.
Here are the top 5 biosimilar articles for the week of April 1, 2024.
Here are the top 5 biosimilar articles for the week of March 25, 2024.
Related Content
© 2024 MJH Life Sciences

All rights reserved.